Table 2.
Hospital and ICU mortality rates for COVID-19 worldwide as compared to other CAP-associated pathogens from solely European and North American studies
| Hospital mortality | ICU mortality | |
|---|---|---|
| CAP in general [7, 15–19] | 12.9–14.1% | 17.0–29.5% |
| S. pneumoniae [18, 20, 21] | 8.0–12.0% | 17.5–26.0% |
| L. pneumonia [22–25] | 3.9–18.5% | 21.6% |
| Viral CAP in general [26, 27] | 14.8% | 22.0% |
| Influenza A/B [10, 19, 28–31] | 12.6% | 17.1–41.2% |
| COVID-19 | ||
| China (Wuhan)a [32–36] | 10.7–21.9% | 61.5% |
| USA (New York)b [37] | 21.0% | 78.0% |
| Europe (ECDC) [2] | 14% | – |
| United Kingdoma [26] | – | 34.8–46.8% |
| Spaina [38] | – | 29.2% |
| Italy (Lombardy)a [39] | – | 25.6% |
a COVID-19 pandemic epicenters
bEpicenter New York: on 23 April 2020 approx. tenfold more SARS-CoV‑2 infected people/100,000 inhabitants and 20-fold more COVID-19 deaths/100,000 inhabitants than in Austria at the same time [40]
CAP community acquired pneumonia, COVID-19 coronavirus disease 2019, ECDC European Centre for Disease Prevention and Control, ICU intensive care unit